APRIL (AbatacePt in Rheumatoid Arthritis-ILD)

NCT03084419 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis
Interstitial Lung Disease

Interventions

DRUG: Abatacept

Sponsor

Cambridge University Hospitals NHS Foundation Trust

Collaborators

[object Object]